WELL Health to Announce Third Quarter 2026 Financial Results on November 9, 2026
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or...
Day: October 30, 2026
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™...
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026 Halle (Saale) / Munich, Germany, October 30, 2026...
Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health
SHANGHAI, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven...
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
Tokyo, Japan and Cambridge, UK, 30 October 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update...
Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded
Q3 2026: double-digit growth in sales and business EPSFY 2026: guidance upgraded October 30, 2026 Q3 sales growth of 14.3%...
Nicox Reports First Half 2026 Financial Results
Press Release Nicox Reports First Half 2026 Financial Results Revenue increased to €3.5 million compared to €1.5 million in H1...
Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein
Dual-Target Approach Designed to Modulate Both Innate and Adaptive Immunity Advances Into Clinical Evaluation in Patients With SLENANJING, China, Oct....
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
PALO ALTO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Following the awarding of the 2026 Nobel Prize in Physiology or...
Aspen Neuroscience Announces Pricing of Initial Public Offering
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative medicine biotechnology company developing...
InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China
BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the...
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions...
Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep,...
Cytek Biosciences to Participate in Upcoming Investor Conferences
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today...
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a...
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration...
Strom Strategies Calls for a Possible “Black Box Warning” on Al Sayed’s Medicare for All Proposal
Dr. Joel Strom raises questions about expanding the ACA, patient choice and the need for clear evidence on the plan’s...
Supernus Announces Third Quarter 2026 Financial Results
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year.Combined...
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basisQ1 GAAP diluted earnings per...